Modulation of the Ribonucleotide Reductase-Antimetabolite Drug Interaction in Cancer Cell Lines

RRM1 is a determinant of gemcitabine efficacy in cancer patients. However, the precision of predicting tumor response based on RRM1 levels is not optimal. We used gene-specific overexpression and RNA interference to assess RRM1's impact on different classes of cytotoxic agents, on drug-drug int...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Zhou, Jun, Oliveira, Paula, Li, Xueli, Chen, Zhengming, Bepler, Gerold
Formato: Artigo
Idioma:Inglês
Publicado: SAGE-Hindawi Access to Research 2010
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952906/
https://ncbi.nlm.nih.gov/pubmed/20976259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2010/597098
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares